RACHEL WHEELER: Open Payments
NPI 1609195734 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 7 companies in 2025. Trend: 2023 $415 · 2024 $456 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Exact Sciences Corporation | 4 | $70 |
| PFIZER INC. | 3 | $64 |
| Amgen Inc. | 2 | $41 |
| Abbott Laboratories | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, REPATHA, PREVNAR 20, The Cologuard Plus Collection Kit, Cologuard Collection Kit, PAXLOVID, JOT DX, QULIPTA.
Industry payments across TX — which companies pay providers there.
